Patents by Inventor Charles David Ogilvy Potter
Charles David Ogilvy Potter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9693951Abstract: An elongate body for parenteral injection at low velocity from a device is described. The body has at least one pointed end and comprises at least one active material. In addition, the body has a compressive strength of greater than or equal to 5 Newton and the pointed end has an included angle of between about 10-50°. A solid vaccine formulation for needle-free parenteral delivery, methods for making the body, packaging of the body and use of the body, packaging and suitable delivery device are also described.Type: GrantFiled: December 3, 2013Date of Patent: July 4, 2017Assignee: GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITEDInventors: Charles David Ogilvy Potter, Shohre Nabahi
-
Patent number: 9693952Abstract: An elongate body for parenteral injection at low velocity from a device is described. The body has at least one pointed end and comprises at least one active material. In addition, the body has a compressive strength of greater than or equal to 5 Newton and the pointed end has an included angle of between about 10-50°. A solid vaccine formulation for needle-free parenteral delivery, methods for making the body, packaging of the body and use of the body, packaging and suitable delivery device are also described.Type: GrantFiled: July 5, 2016Date of Patent: July 4, 2017Assignee: GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITEDInventors: Charles David Ogilvy Potter, Shohre Nabahi
-
Publication number: 20160310413Abstract: An elongate body for parenteral injection at low velocity from a device is described. The body has at least one pointed end and comprises at least one active material. In addition, the body has a compressive strength of greater than or equal to 5 Newton and the pointed end has an included angle of between about 10-50°. A solid vaccine formulation for needle-free parenteral delivery, methods for making the body, packaging of the body and use of the body, packaging and suitable delivery device are also described.Type: ApplicationFiled: July 5, 2016Publication date: October 27, 2016Inventors: Charles David Ogilvy POTTER, Shohre NABAHI
-
Patent number: 9072472Abstract: The invention relates to devices used in the fields of drag delivery or sampling. More particularly, it relates to a disposable assembly which is fitted to an actuator device which causes the skin piercing element to enter the skin to deliver a drug (or other substance) or take a sample. Preferably the assembly is “made safe” after actuation, such that the disposable assembly can't be reused and more preferably still the skin piercing element is safely housed in the assembly such that it does not constitute a “sharps” risk.Type: GrantFiled: February 7, 2006Date of Patent: July 7, 2015Assignee: GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITEDInventors: Charles David Ogilvy Potter, David Stuart Potter, Graeme Paterson
-
Publication number: 20140093553Abstract: An elongate body for parenteral injection at low velocity from a device is described. The body has at least one pointed end and comprises at least one active material. In addition, the body has a compressive strength of greater than or equal to 5 Newton and the pointed end has an included angle of between about 10-50°. A solid vaccine formulation for needle-free parenteral delivery, methods for making the body, packaging of the body and use of the body, packaging and suitable delivery device are also described.Type: ApplicationFiled: December 3, 2013Publication date: April 3, 2014Inventors: Charles David Ogilvy POTTER, Shohre NABAHI
-
Patent number: 8574188Abstract: The invention relates to a novel drug delivery technology. More particularly the invention relates to a method of delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient; to a throwaway or reusable device for delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient in a manner as set out by the method; to a pioneer projectile for use in said method; to formulations for use in said method and to an injectate comprising a pioneer projectile and formulation. It also relates to a disposable component containing either a pioneer projectile or an injectate. The invention also relates to a throwaway or reusable device for delivering at least one therapeutic compound, or a formulation comprising the at least one therapeutic compound (hereafter drug) to a patient, and a method for administering a drug to a patient using said device.Type: GrantFiled: August 25, 2011Date of Patent: November 5, 2013Assignee: Glide Pharmaceutical Technologies LimitedInventors: David Stuart Potter, Charles David Ogilvy Potter
-
Publication number: 20110313348Abstract: The invention relates to a novel drug delivery technology. More particularly the invention relates to a method of delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient; to a throwaway or reusable device for delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient in a manner as set out by the method; to a pioneer projectile for use in said method; to formulations for use in said method and to an injectate comprising a pioneer projectile and formulation. It also relates to a disposable component containing either a pioneer projectile or an injectate. The invention also relates to a throwaway or reusable device for delivering at least one therapeutic compound, or a formulation comprising the at least one therapeutic compound (hereafter drug) to a patient, and a method for administering a drug to a patient using said device.Type: ApplicationFiled: August 25, 2011Publication date: December 22, 2011Applicant: GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED,Inventors: David Stuart POTTER, Charles David Ogilvy Potter
-
Patent number: 7727223Abstract: The invention relates to a novel drug delivery technology. More particularly the invention relates to a method of delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient: to a throwaway or reusable device for delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient in a manner as set out by the method; to a pioneer projectile form use in said method; to formulations for use in said method and to an injectate comprising a pioneer projectile and formulation. It also relates to a disposable component containing either a pioneer projectile or an injectate.Type: GrantFiled: September 10, 2002Date of Patent: June 1, 2010Assignee: Glide Pharmaceutical Technologies LimitedInventors: Charles David Ogilvy Potter, David Stuart Potter
-
Publication number: 20100119570Abstract: An elongate body for parenteral injection at low velocity from a device is described. The body has at least one pointed end and comprises at least one active material. In addition, the body has a compressive strength of greater than or equal to 5 Newton and the pointed end has an included angle of between about 10-50°. A solid vaccine formulation for needle-free parenteral delivery, methods for making the body, packaging of the body and use of the body, packaging and suitable delivery device are also described.Type: ApplicationFiled: February 20, 2008Publication date: May 13, 2010Applicant: GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITEDInventors: Charles David Ogilvy Potter, Shohre Nabahi
-
Patent number: 7615234Abstract: The invention relates to a novel drug delivery technology. More particularly the invention relates to a method of delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient; to a throwaway or reusable device for delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient in a manner as set out by the method; to a pioneer projectile for use in said method; to formulations for use in said method and to an injectate comprising a pioneer projectile and formulation. It also relates to a disposable component containing either a pioneer projectile or an injectate. The invention also relates to a throwaway or reusable device for delivering at least one therapeutic compound, or a formulation comprising the at least one therapeutic compound (hereafter drug) to a patient, and a method for administering a drug to a patient using said device.Type: GrantFiled: September 10, 2002Date of Patent: November 10, 2009Assignee: Glide Pharmaceutical Technologies LimitedInventors: David Stuart Potter, Charles David Ogilvy Potter
-
Publication number: 20090030442Abstract: The invention relates to devices used in the fields of drag delivery or sampling. More particularly, it relates to a disposable assembly which is fitted to an actuator device which causes the skin piercing element to enter the skin to deliver a drug (or other substance) or take a sample. Preferably the assembly is “made safe” after actuation, such that the disposable assembly can't be reused and more preferably still the skin piercing element is safely housed in the assembly such that it does not constitute a “sharps” risk.Type: ApplicationFiled: February 7, 2006Publication date: January 29, 2009Inventors: Charles David Ogilvy Potter, David Stuart Potter, Graeme Paterson
-
Patent number: 7207967Abstract: A needleless syringe particle delivery system is provided. The needleless syringe has an elongate nozzle that is connected at its upstream end to a sealed chamber. The sealed chamber contains gas at super-atmospheric pressure and particles of a therapeutic agent. Upon release of the gas from the sealed chamber, a flow is formed which entrains the particles and allows the particles to pass through the nozzle at supersonic speed for subsequent delivery to a target surface.Type: GrantFiled: February 13, 1997Date of Patent: April 24, 2007Assignee: PowderJect Research LimitedInventors: Brian John Bellhouse, Paul Rudd Drayson, John Christopher Greenford, Charles David Ogilvy Potter, David Francis Sarphie
-
Publication number: 20030054044Abstract: The invention relates to a novel drug delivery technology. More particularly the invention relates to a method of delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient; to a throwaway or reusable device for delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient in a manner as set out by the method; to a pioneer projectile for use in said method; to formulations for use in said method and to an injectate comprising a pioneer projectile and formulation. It also relates to a disposable component containing either a pioneer projectile or an injectate. The invention also relates to a throwaway or reusable device for delivering at least one therapeutic compound, or a formulation comprising the at least one therapeutic compound (hereafter drug) to a patient, and a method for administering a drug to a patient using said device.Type: ApplicationFiled: September 10, 2002Publication date: March 20, 2003Inventors: David Stuart Potter, Charles David Ogilvy Potter
-
Patent number: 6004286Abstract: A needleless syringe, in which particles of a therapeutic agent are entrained in a high pressure gas flow, has a nozzle surrounded by a shroud silencer through which gas reflected from the target surface may be vented to atmosphere while retaining any particles reflected in the gas.Type: GrantFiled: September 18, 1998Date of Patent: December 21, 1999Assignee: PowderJect Research LimitedInventors: Brian John Bellhouse, Charles David Ogilvy Potter, John Christopher Greenford
-
Patent number: 5766207Abstract: A driver for at least one pneumatically-actuated ventricular assist device (VAD), includes a portable housing which encloses a single pump for performing blood-filling and blood-emptying operations of the VAD, a switching valve for alternately communicating the inlet and outlet of the pump with the VAD, a vacuum relief device for subjecting the VAD to negative pressure when performing blood-filling, a battery, and a controller for controlling operation of the driver. The use of a single pump enables the driver to be fully portable. A novel blood pumping system and a method of using the same are also disclosed.Type: GrantFiled: December 23, 1996Date of Patent: June 16, 1998Assignee: Thoratec Laboratories CorporationInventors: David Stuart Potter, Dereck Ronald Wheeldon, Terrence Michael McCarthy, Charles David Ogilvy Potter